FDA action alert: ARS Pharma, Appili, Ocuphire, and BrainStorm Therapeutics The FDA will finish September with three action dates and one of the year’s most highly-anticipated advisory committee meetings. Read more September 18, 2023/by BioSpace https://www.pharmalive.com/wp-content/uploads/2023/05/BiospaceFDA5-30-2023.jpg 350 625 BioSpace https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png BioSpace2023-09-18 08:06:262023-09-18 08:07:43FDA action alert: ARS Pharma, Appili, Ocuphire, and BrainStorm
